Clinical Trials | January 17, 2026
GCCL and OPIS forge global clinical trial alliance
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
The company plans to add 1700 beds by FY27 through the organic route
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Both the India and GCC entities will be operated by separate dedicated management teams
Dr. Peter Houghton will lead the research collaboration for GCCRI and is widely regarded as a leading expert in pediatric cancer research and in the development of novel approaches to treating childhood cancers
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The plant is expected to enhance regional supply capabilities
Subscribe To Our Newsletter & Stay Updated
